Response by FDA to KEI’s FOIA Request Regarding the PSM India Summit of May 11, 2010 in New Delhi

In June of 2010, KEI was informed that representatives from the the United States Food and Drug Administration (FDA) had recently attended a summit in India on the issue of counterfeited and spurious medicines organized by the Partnership for Safe Medicines (PSM), a US-based organization with clear links to pharmaceutical corporate interests.

Continue Reading

Uncategorized

SCP15: KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights

KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP 15
13 October 2010

Thank you Mr. Chair.

We take note of Professor Coenraad Visser’s study which examined ‘Selected Case Studies of Countries Where Compulsory Licences Have Been Granted for Pharmaceuticals’.

Continue Reading

Uncategorized

KEI general statement to the 15th Standing Committee on the Law of Patents (SCP)

SCP 15
General Statement of Knowledge Ecology International
12 October 2010

Thank you Mr. Chair, and I would like to take this opportunity to congratulate you and the vice-chairs upon your re-election.

1. Knowledge Ecology International welcomes the reports by experts, thanks the Secretariat for its work on this topic.

As a general matter, KEI suggests the WIPO Secretariat provide standardized disclosure of the professional consulting that various experts do, as is the practice for other UN bodies and some academic journals.

Continue Reading

Uncategorized